Insights about U.S. Stocks that landed in the Red-Zone during Tuesday’s trade, are depicted underneath:
ImmunoGen, Inc.(NASDAQ:IMGN)’s shares dwindled -4.44%, and closed at $7.54.The stock volatility for the week is 5.69%, while for the month remained 5.16%. The mean recommendation of analysts for this stock is 2.70. (where 1=Buy, 5=Sale).
ImmunoGen, Inc., a biotechnology corporation, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology.
Uranium Energy Corp (NYSEMKT:UEC), declined -4.41 %, and closed at $1.30. The stock has the beta value of 1.69, and its volatility for the week is 6.60%, while for the month it is 6.69%. The company has the market capitalization of $124.77M. The mean recommendation of analysts for this stock is 1.80.(where 1=Buy, 5=Sale).
Uranium Energy Corp. engages in the exploration, extraction, and processing of uranium concentrates on projects located in the United States and the Republic of Paraguay.
SandRidge Energy Inc (NYSE:SD), dipped -4.40 %, and closed at $1.74.
SandRidge Energy, Inc. (SD), posted financial and operational results for the period ended December 31, 2014.
Key Financial Results:
Fourth Quarter:
- Adjusted EBITDA, pro forma for divestitures and net of noncontrolling interest, was $224 million in the fourth quarter of 2014 contrast to $190 million in the fourth quarter of 2013, 18% year-over-year growth.
- Adjusted operating cash flow of $203 million for fourth quarter 2014 contrast to $243 million in fourth quarter 2013.
- Adjusted net revenue of $44.1 million, or $0.08 per diluted share, for fourth quarter 2014 contrast to $39.2 million, or $0.07 per diluted share, in fourth quarter 2013.
- Full Year
- Adjusted EBITDA, pro forma for divestitures and net of non-controlling interest, was $820 million in 2014 contrast to $609 million in 2013, 35% year-over-year growth.
- Adjusted operating cash flow of $712 million for 2014 contrast to $812 million in 2013.
- Adjusted net revenue of $149.9 million, or $0.26 per diluted share, for 2014 contrast to $103.9 million, or $0.18 per diluted share, in 2013.
SandRidge Energy, Inc., an oil and natural gas corporation, explores for and produces oil and natural gas properties primarily in the Mid-Continent region of the United States.
Idera Pharmaceuticals Inc (NASDAQ:IDRA), dropped -4.34 %, and closed at $4.63.
Idera Pharmaceuticals, Inc. (IDRA), formerly on February 19, declared the closing of its formerly declared underwritten public offering of 23,000,000 shares of ordinary stock at an offering price of $3.75 per share. The shares of ordinary stock in the offering comprise 3,000,000 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares at the offering price. The gross proceeds to Idera from this offering total $86.25 million, before underwriting discounts and commissions and offering expenses. Goldman, Sachs & Co. and J.P. Morgan acted as joint book-running managers for the offering. Piper Jaffray & Co. acted as lead manager for the offering.
Idera Pharmaceuticals, Inc., a clinical stage biotechnology corporation, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States.
